These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6491918)

  • 1. Sulpiride pharmacokinetics in humans after intramuscular administration at three dose levels.
    Bressolle F; Bres J; Blanchin MD; Gomeni R
    J Pharm Sci; 1984 Aug; 73(8):1128-36. PubMed ID: 6491918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations.
    Brès J; Bressolle F
    J Pharm Sci; 1991 Dec; 80(12):1119-24. PubMed ID: 1815069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
    Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
    Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans.
    Bressolle F; Brès J; Fauré-Jeantis A
    J Pharm Sci; 1992 Jan; 81(1):26-32. PubMed ID: 1619566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function.
    Bressolle F; Brès J; Mourad G
    Clin Pharmacokinet; 1989 Nov; 17(5):367-73. PubMed ID: 2582694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of sulpiride after oral and intravenous administration in the rat and the dog.
    Segura J; Borja L; Bakke OM
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):88-95. PubMed ID: 999405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double-peak absorption profile after oral administration to human volunteers.
    Helmy SA
    Biopharm Drug Dispos; 2013 Jul; 34(5):288-301. PubMed ID: 23585286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of vincristine sulfate in children.
    Sethi VS; Kimball JC
    Cancer Chemother Pharmacol; 1981; 6(2):111-5. PubMed ID: 7307229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
    Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
    Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of 14C-sulpiride in dogs.
    Alam AS; Imondi AR; Udinsky J; Hagerman LM
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):4-13. PubMed ID: 543747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of single-dose cefmetazole following intramuscular administration of cefmetazole sodium to healthy male volunteers.
    Ko H; Novak E; Peters GR; Bothwell WM; Hosley JD; Closson SK; Adams WJ
    Antimicrob Agents Chemother; 1989 Apr; 33(4):508-12. PubMed ID: 2729944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new trifluorinated quinolone: Ro 23-6240 (AM 833).
    Weidekamm E; Stöckel K; Dell D
    Drugs Exp Clin Res; 1987; 13(2):85-90. PubMed ID: 3107959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Mar; 66(3):395-407. PubMed ID: 845807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, urinary excretion and dosage regimen of diminazene in crossbred calves.
    Kaur G; Chaudhary RK; Srivastava AK
    Acta Vet Hung; 2000; 48(2):187-92. PubMed ID: 11402701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of 6beta-naltrexol after single and multiple intramuscular injections in Beagle dogs].
    Yan LD; Liu J; Dong HJ; Cui MX; Yao XJ; Liu YS; Gong ZH; Gong ZH
    Yao Xue Xue Bao; 2009 Jul; 44(7):722-5. PubMed ID: 19806909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.
    Chen TL; Vogelsang GB; Petty BG; Brundrett RB; Noe DA; Santos GW; Colvin OM
    Drug Metab Dispos; 1989; 17(4):402-5. PubMed ID: 2571480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.